Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marina A. J. Tijssen is active.

Publication


Featured researches published by Marina A. J. Tijssen.


Neuron | 2004

Mutations in the Na+/K+-ATPase α3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism

Patricia de Carvalho Aguiar; Kathleen J. Sweadner; John T. Penniston; Jacek Zaremba; Liu Liu; Marsha Caton; Gurutz Linazasoro; Michel Borg; Marina A. J. Tijssen; Susan Bressman; William B. Dobyns; Allison Brashear; Laurie J. Ozelius

Rapid-onset dystonia-parkinsonism (RDP, DYT12) is a distinctive autosomal-dominant movement disorder with variable expressivity and reduced penetrance characterized by abrupt onset of dystonia, usually accompanied by signs of parkinsonism. The sudden onset of symptoms over hours to a few weeks, often associated with physical or emotional stress, suggests a trigger initiating a nervous system insult resulting in permanent neurologic disability. We report the finding of six missense mutations in the gene for the Na+/K+ -ATPase alpha3 subunit (ATP1A3) in seven unrelated families with RDP. Functional studies and structural analysis of the protein suggest that these mutations impair enzyme activity or stability. This finding implicates the Na+/K+ pump, a crucial protein responsible for the electrochemical gradient across the cell membrane, in dystonia and parkinsonism.


Movement Disorders | 2006

Deep Brain Stimulation in Tourette's Syndrome: Two Targets?

Linda Ackermans; Yasin Temel; Danielle C. Cath; Chris van der Linden; Richard Bruggeman; Mariska Kleijer; Pieter Nederveen; Koen Schruers; H. Colle; Marina A. J. Tijssen; Veerle Visser-Vandewalle

In this report, we describe the effects of bilateral thalamic stimulation in one patient and of bilateral pallidal stimulation in another patient. Both patients suffered from intractable Tourette’s syndrome (TS). Any conservative treatment had failed or had been stopped because of unbearable side effects in the 2 patients. In both cases, there was no comorbidity except for associated behavioral symptoms (compulsions). Electrodes were implanted at the level of the medial part of the thalamus (centromedian nucleus, the substantia periventricularis, and the nucleus ventro‐oralis internus) in one patient and in the posteroventral part of the globus pallidus internus (GPi) in the other patient. In both cases, deep brain stimulation (DBS) resulted in a substantial reduction of tics and compulsions. These data show that bilateral DBS of the thalamus as well as of the GPi can have a good effect on tics and behavioral symptoms in patients suffering from intractable TS.


Nature Genetics | 2006

Mutations in the gene encoding GlyT2 ( SLC6A5 ) define a presynaptic component of human startle disease

Mark I. Rees; Kirsten Harvey; Brian R. Pearce; Seo-Kyung Chung; Ian Duguid; Philip Thomas; Sarah E. Beatty; Gail E. Graham; Linlea Armstrong; Rita Shiang; Kim J. Abbott; Sameer M. Zuberi; John B.P. Stephenson; Michael John Owen; Marina A. J. Tijssen; Arn M. J. M. van den Maagdenberg; Trevor G. Smart; Stéphane Supplisson; Robert J. Harvey

Hyperekplexia is a human neurological disorder characterized by an excessive startle response and is typically caused by missense and nonsense mutations in the gene encoding the inhibitory glycine receptor (GlyR) α1 subunit (GLRA1). Genetic heterogeneity has been confirmed in rare sporadic cases, with mutations affecting other postsynaptic glycinergic proteins including the GlyR β subunit (GLRB), gephyrin (GPHN) and RhoGEF collybistin (ARHGEF9). However, many individuals diagnosed with sporadic hyperekplexia do not carry mutations in these genes. Here we show that missense, nonsense and frameshift mutations in SLC6A5 (ref. 8), encoding the presynaptic glycine transporter 2 (GlyT2), also cause hyperekplexia. Individuals with mutations in SLC6A5 present with hypertonia, an exaggerated startle response to tactile or acoustic stimuli, and life-threatening neonatal apnea episodes. SLC6A5 mutations result in defective subcellular GlyT2 localization, decreased glycine uptake or both, with selected mutations affecting predicted glycine and Na+ binding sites.


European Journal of Neuroscience | 2005

The relationship between oscillatory activity and motor reaction time in the parkinsonian subthalamic nucleus.

David Williams; Andrea A. Kühn; Marina A. J. Tijssen; Gerard van Bruggen; Hans Speelman; Gary Hotton; Constantinos Loukas; Peter Brown

Averaging techniques have demonstrated that movement preparatory cues and movement itself are associated with marked reductions in the oscillatory synchrony of local neuronal populations in the area of the human parkinsonian subthalamic nucleus (STN), as indexed by 8–30 Hz local field potential (LFP) activity. In order to examine the detailed nature and strength of the relationship between reductions in oscillatory activity and movement we examined single‐trial LFP activity recorded from the STN area of parkinsonian subjects engaged in a choice reaction task. In this task an initial warning cue was either fully predictive or non‐predictive of the hand required to make a later motor response. This motor response was elicited by a second go cue to which data were aligned. We observed a significant linear relationship between the onset time of oscillation reduction after go cues and subsequent motor response time across single trials within subjects. Consistent with this observation we also found a positive correlation of power with response time following go cues. In addition, we observed shorter durations of suppression in fully predictive trials where selection of the response could precede go cue presentation. The results are consistent with the hypothesis that reductions in 8–30 Hz population synchrony in the STN area are related to the processing required for motor preparation, particularly response selection.


Neurology | 2009

Clinical spectrum of ataxia-telangiectasia in adulthood

Mijke M.M. Verhagen; W. F. Abdo; M.A.A.P. Willemsen; Frans B. L. Hogervorst; Dominique Smeets; J.A.P. Hiel; Ewout Brunt; M. A. van Rijn; D. Majoor Krakauer; Rogier A. Oldenburg; Annegien Broeks; L. J. van’t Veer; Marina A. J. Tijssen; A. M.I. Dubois; H. P.H. Kremer; Corry Weemaes; A.M.R. Taylor; M. van Deuren

Objective: To describe the phenotype of adult patients with variant and classic ataxia-telangiectasia (A-T), to raise the degree of clinical suspicion for the diagnosis variant A-T, and to assess a genotype–phenotype relationship for mutations in the ATM gene. Methods: Retrospective analysis of the clinical characteristics and course of disease in 13 adult patients with variant A-T of 9 families and 6 unrelated adults with classic A-T and mutation analysis of the ATM gene and measurements of ATM protein expression and kinase activity. Results: Patients with variant A-T were only correctly diagnosed in adulthood. They often presented with extrapyramidal symptoms in childhood, whereas cerebellar ataxia appeared later. Four patients with variant A-T developed a malignancy. Patients with classic and variant A-T had elevated serum α-fetoprotein levels and chromosome 7/14 rearrangements. The mildest variant A-T phenotype was associated with missense mutations in the ATM gene that resulted in expression of some residual ATM protein with kinase activity. Two splicing mutations, c.331 + 5G>A and c.496 + 5G>A, caused a more severe variant A-T phenotype. The splicing mutation c.331 + 5G>A resulted in less ATM protein and kinase activity than the missense mutations. Conclusions: Ataxia-telangiectasia (A-T) should be considered in patients with unexplained extrapyramidal symptoms. Early diagnosis is important given the increased risk of malignancies and the higher risk for side effects of subsequent cancer treatment. Measurement of serum α-fetoprotein and chromosomal instability precipitates the correct diagnosis. There is a clear genotype–phenotype relation for A-T, since the severity of the phenotype depends on the amount of residual kinase activity as determined by the genotype.


Annals of Neurology | 2013

Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene

Katja Lohmann; Robert A. Wilcox; Susen Winkler; Alfredo Ramirez; Aleksandar Rakovic; Jin-Sung Park; Björn Arns; Thora Lohnau; Justus L. Groen; Meike Kasten; Norbert Brüggemann; Johann Hagenah; Alexander Schmidt; Frank J. Kaiser; Kishore R. Kumar; Katja Zschiedrich; Daniel Alvarez-Fischer; Eckart Altenmüller; A. Ferbert; Anthony E. Lang; Alexander Münchau; Vladimir Kostic; Kristina Simonyan; Mj Agzarian; Laurie J. Ozelius; Antonius P. M. Langeveld; Carolyn M. Sue; Marina A. J. Tijssen; Christine Klein

A study was undertaken to identify the gene underlying DYT4 dystonia, a dominantly inherited form of spasmodic dysphonia combined with other focal or generalized dystonia and a characteristic facies and body habitus, in an Australian family.


Movement Disorders | 2013

The anatomical basis of dystonia: Current view using neuroimaging

Stéphane Lehéricy; Marina A. J. Tijssen; Marie Vidailhet; Ryuji Kaji; Sabine Meunier

This review will consider the knowledge that neuroimaging studies have provided to the understanding of the anatomy of dystonia. Major advances have occurred in the use of neuroimaging for dystonia in the past 2 decades. At present, the most developed imaging approaches include whole‐brain or region‐specific studies of structural or diffusion changes, functional imaging using fMRI or positron emission tomography (PET), and metabolic imaging using fluorodeoxyglucose PET. These techniques have provided evidence that regions other than the basal ganglia are involved in dystonia. In particular, there is increasing evidence that primary dystonia can be viewed as a circuit disorder, involving the basal ganglia‐thalamo‐cortical and cerebello‐thalamo‐cortical pathways. This suggests that a better understanding of the dysfunction in each region in the network and their interactions are important topics to address. Current views of interpretation of imaging data as cause or consequence of dystonia, and the postmortem correlates of imaging data are presented. The application of imaging as a tool to monitor therapy and its use as an outcome measure will be discussed.


NeuroImage | 2011

Structural, functional and molecular imaging of the brain in primary focal dystonia--a review.

Evelien Zoons; Jan Booij; Aart J. Nederveen; Joke M. Dijk; Marina A. J. Tijssen

Primary focal dystonias form a group of neurological disorders characterized by involuntary, sustained muscle contractions causing twisting movements and abnormal postures. The estimated incidence is 12-25 per 100,000. The pathophysiology is largely unclear but genetic and environmental influences are suspected. Over the last decade neuroimaging techniques have been applied in patients with focal dystonia. Using structural, functional and molecular imaging techniques, abnormalities have been detected mainly in the sensorimotor cortex, basal ganglia and cerebellum. The shared anatomical localisations in different forms of focal dystonia support the hypothesis of a common causative mechanism. The primary defect in focal dystonia is hypothesised in the motor circuit connecting the cortex, basal ganglia, and cerebellum. Imaging techniques have clearly enhanced current knowledge on the pathophysiology of primary focal dystonia and will continue to do so in the future.


European Journal of Neuroscience | 2005

Reciprocal interactions between oscillatory activities of different frequencies in the subthalamic region of patients with Parkinson's disease.

Noa Fogelson; Alek Pogosyan; Andrea A. Kühn; Gerard van Bruggen; Hans Speelman; Marina A. J. Tijssen; Angelo Quartarone; Angelo Insola; Paolo Mazzone; Vincenzo Di Lazzaro; Patricia Limousin; Peter Brown

Synchronization of neuronal activity evident in the local field potential (LFP) recorded in the subthalamic region of patients with Parkinsons disease occurs at low frequencies (< 30 Hz) and, in some patients following treatment with levodopa, at high frequencies between 65 and 85 Hz. Here we investigate the functional relationship between these different activities by determining whether spontaneous fluctuations in their strength are correlated across time. To this end, we analysed recordings of LFPs from macroelectrodes inserted in the subthalamic area of 16 patients with Parkinsons disease, after treatment with anti‐parkinsonian medication. Time‐evolving autospectra of LFPs with significant 65–85 Hz peaks (from 21 sides) were computed and correlations between frequency components determined over time. LFP activity in the 5–32 Hz band was significantly negatively correlated with that in the 65–85 Hz band in data averaged across all 21 sides, as well as in 15 (71%) of the individual records. Negative correlations were relatively selective for interactions between these frequency bands and occurred over time epochs of as little as 40 s. They occurred about 50 min after levodopa and were recorded concurrently with contralateral levodopa‐induced dyskinesias in all but four cases. Positive correlations were not seen between activities in the 5–32 Hz and 65–85 Hz bands. The spontaneous negative correlations suggest a reciprocal relationship between population synchrony in the high‐ and low‐frequency ranges, and raise the possibility that spontaneous fluctuations in the balance between these activities may contribute to levodopa‐induced dyskinesias.


Annals of Neurology | 2012

Sepiapterin reductase deficiency: A Treatable Mimic of Cerebral Palsy

Jennifer Friedman; Emmanuel Roze; Jose E. Abdenur; Richard Chang; Serena Gasperini; Veronica Saletti; Gurusidheshwar M. Wali; Hernan Eiroa; Brian Neville; Alex E. Felice; Ray Parascandalo; Dimitrios I. Zafeiriou; Luisa Arrabal‐Fernandez; Patricia Dill; Florian Eichler; Bernard Echenne; Luis González Gutiérrez-Solana; Georg F. Hoffmann; Keith Hyland; Katarzyna Kusmierska; Marina A. J. Tijssen; Thomas A. Lutz; Michel Mazzuca; Johann Penzien; Bwee Tien Poll-The; Jolanta Sykut-Cegielska; Krystyna Szymańska; Beat Thöny; Nenad Blau

Sepiapterin reductase deficiency (SRD) is an under‐recognized levodopa‐responsive disorder. We describe clinical, biochemical, and molecular findings in a cohort of patients with this treatable condition. We aim to improve awareness of the phenotype and available diagnostic and therapeutic strategies to reduce delayed diagnosis or misdiagnosis, optimize management, and improve understanding of pathophysiologic mechanisms.

Collaboration


Dive into the Marina A. J. Tijssen's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hendriekje Eggink

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Frank Baas

University of Amsterdam

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Deborah A. Sival

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Jan Willem Elting

University Medical Center Groningen

View shared research outputs
Researchain Logo
Decentralizing Knowledge